Skip to main content
Premium Trial:

Request an Annual Quote

Paired Ends: Naveed Aziz, Ivan Trifunovich, Brett Ammundsen, and Others

Premium

Naveed Aziz has joined Genome Canada as director of technology programs, where he will focus on the organization's Science and Technology Innovation Centers, technology development, and bioinformatics. He joins Genome Canada from the University of York, where he served as head of genomics.

He holds a PhD in genetic engineering from the Scottish Crop Research Institute at the University of Dundee, and a masters in biotechnology from the National Institute of Biotechnology and Genetic Engineering at Quaid-i-Azam University Islamabad, and is pursuing an MBA from the University of Bradford School of Management.



Helicos BioSciences
CEO Ivan Trifunovich has taken on the role of president and CEO of WaferGen Biosystems, and will remain CEO of Helicos on a part-time basis. Prior to Helicos, Trifunovich served as senior vice president of Third Wave Technologies.

He holds a PhD in organic chemistry from the University of California, Los Angeles, and an MBA from the University of Pennsylvania's Wharton School of Business.


Genomics software company Biomatters has appointed Brett Ammundsen from managing director to CEO, where he will lead the company as it moves from research applications into the clinical and consumer markets.

He holds a BA in history and a PhD in chemistry and physics from Victoria University of Wellington in New Zealand.


David Botstein, Eric Lander, and Craig Venter will share the 2012 Dan David Prize, and will split the $1 million prize the award carries.

The awards are provided in three categories — past, present, and future – and this trio of scientists won the future award for genomics research. The awards are named for Dan David, a businessman and philanthropist who died in 2011. The three winners have been recognized for their contributions to the Human Genome Project and an array of genomics research efforts, from developing microarrays and DNA sequencing technologies to computational genomics and SNP mapping, and launching labs, companies, and institutes that have driven cutting-edge genomics.

Botstein currently is a director of the Lewis-Sigler Institute for Integrative Genomics at Princeton University. Venter is founder, chairman, and president of the J. Craig Venter Institute, as well as the Institute for Genomic Research, and Celera Genomics. Lander is founding director of the Broad Institute of Harvard and MIT and director of its Genome Biology Program.

The Scan

Study Follows Consequences of Early Confirmatory Trials for Accelerated Approval Indications

Time to traditional approval or withdrawal was shorter when confirmatory trials started prior to accelerated approval, though overall regulatory outcomes remained similar, a JAMA study finds.

Sequencing Study Leads to Vaccine Target in Bacteria Behind Neonatal Meningitis

Researchers eBioMedicine track down potential vaccine targets with transposon sequencing on mutant bacteria causing neonatal meningitis in mouse models of the disease.

Multiple Myeloma Progression Influenced by Immune Microenvironment Expression

Researchers in NPJ Genomic Medicine compare RNA sequencing profiles of 102,207 individual cells in bone marrow samples from 18 individuals with rapid or non-progressing multiple myeloma.

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.